{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:21:17Z","timestamp":1779891677456,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.braindev.2026.104512","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:02:56Z","timestamp":1771358576000},"page":"104512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An increase in cerebrospinal fluid macrophage migration inhibitory factor levels in pediatric patients with acute neuroinflammatory diseases: A preliminary study"],"prefix":"10.1016","volume":"48","author":[{"given":"Masaru","family":"Nasuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Motobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2026.104512_bb0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"Bloom","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.braindev.2026.104512_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.braindev.2026.104512_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/med.21385","article-title":"Targeting MIF in Cancer: therapeutic strategies, current developments, and future opportunities","volume":"36","author":"O\u2019Reilly","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.braindev.2026.104512_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-023-02993-6","article-title":"MIF contribution to progressive brain diseases","volume":"21","author":"Matejuk","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.braindev.2026.104512_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.braindev.2026.104512_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.braindev.2026.104512_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8917804","article-title":"Macrophage polarization in chronic inflammatory diseases: killers or builders?","volume":"2018","author":"Parisi","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.braindev.2026.104512_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/ol.2025.14910","article-title":"Macrophage migration inhibitory factor in inflammasome formation and macrophage recruitment by cervical squamous cell carcinoma cells","volume":"29","author":"Zhang","year":"2025","journal-title":"Oncol Lett"},{"key":"10.1016\/j.braindev.2026.104512_bb0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.braindev.2026.104512_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104512_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1542\/peds.2010-3318","article-title":"Neurodiagnostic evaluation of the child with a simple febrile seizure","volume":"127","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2026.104512_bb0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3389\/fimmu.2019.00792","article-title":"Macrophage polarization in physiological and pathological pregnancy","volume":"10","author":"Yao","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.braindev.2026.104512_bb0065","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.18632\/oncotarget.13739","article-title":"Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.braindev.2026.104512_bb0070","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/cc7933","article-title":"Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection","volume":"13","author":"\u00d8stergaard","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.braindev.2026.104512_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cyto.2015.11.021","article-title":"Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis","volume":"78","author":"Das","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.braindev.2026.104512_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-017-0898-2","article-title":"The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis","volume":"14","author":"Grygorczuk","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.braindev.2026.104512_bb0085","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1172\/JCI32218","article-title":"Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion","volume":"117","author":"Arjona","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.braindev.2026.104512_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2017.06.021","article-title":"Macrophage migration inhibitory factor: a multifaceted cytokine implicated in multiple neurological diseases","volume":"301","author":"Leyton-Jaimes","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.braindev.2026.104512_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.braindev.2019.11.002","article-title":"Serum and cerebrospinal fluid cytokines in children with acute encephalopathy","volume":"42","author":"Kawahara","year":"2020","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2026.104512_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.braindev.2026.104512_bb0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.braindev.2026.104512_bb0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.braindev.2026.104512_bb0115","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1073\/pnas.95.19.11383","article-title":"Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria","volume":"95","author":"Calandra","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.braindev.2026.104512_bb0120","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/onc.2017.1","article-title":"Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy","volume":"36","author":"Castro","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.braindev.2026.104512_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00431-025-06047-2","article-title":"Febrile infection-related epilepsy syndrome (FIRES) in children: a retrospective cohort study","volume":"184","author":"Saad","year":"2025","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.braindev.2026.104512_bb0130","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104512_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2023.09.008","article-title":"Febrile infection-related epilepsy syndrome in childhood: a clinical review and practical approach","volume":"111","author":"van Baalen","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2026.104512_bb0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/epi.16788","article-title":"Inflammation, ictogenesis, and epileptogenesis: an exploration through human disease","volume":"62","author":"Tan","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104512_bb0145","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ana.25439","article-title":"Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome","volume":"85","author":"Clarkson","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2026.104512_bb0150","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2026.104512_bb0155","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2026.104512_bb0160","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.braindev.2026.104512_bb0165","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2026.104512_bb0170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/acn3.51308","article-title":"Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome","volume":"8","author":"Horino","year":"2021","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:45:04Z","timestamp":1773758704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760426000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0387760426000136"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104512","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An increase in cerebrospinal fluid macrophage migration inhibitory factor levels in pediatric patients with acute neuroinflammatory diseases: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104512"}}